About Aphea.Bio
Aphea.Bio is a company based in Zwijnaarde (Belgium) founded in 2017 by Steven Vandenabeele and Isabel Vercauteren. Aphea.Bio has raised $108.83 million across 6 funding rounds from investors including KU Leuven, BNP Paribas Fortis and Gates Foundation. The company has 40 employees as of December 31, 2022. Aphea.Bio operates in a competitive market with competitors including Anorel, Minagro and SOLENA, among others.
- Headquarter Zwijnaarde, Belgium
- Employees 40 as on 31 Dec, 2022
- Founders Steven Vandenabeele, Isabel Vercauteren
-
Sectors
Agriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aphea.Bio
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$108.83 M (USD)
in 6 rounds
-
Latest Funding Round
$2.07 M (USD), Series C
Nov 05, 2024
-
Investors
KU Leuven
& 16 more
-
Employee Count
40
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Aphea.Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Aphea.Bio
Aphea.Bio has successfully raised a total of $108.83M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $2.07 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aphea.Bio
Aphea.Bio has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include KU Leuven, BNP Paribas Fortis and Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A European venture capital fund focused on deep tech investments.
|
Locked | Locked | Locked | |
|
Sustainable investing in conscious consumer, energy transition, and healthy living sectors.
|
Locked | Locked | Locked | |
|
Venture capital is provided by ECBF for bioeconomy transformation.
|
Locked | Locked | Locked |
Investor details for Aphea.Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aphea.Bio
Investment portfolio details for Aphea.Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aphea.Bio
Detailed financials for Aphea.Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aphea.Bio Comparisons
Peer comparison for Aphea.Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aphea.Bio
Aphea.Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anorel, Minagro and SOLENA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diversified crop biological solutions are provided for farmers.
|
|
| Locked | Locked | Locked |
Diversified biological crop solutions are provided to farmers.
|
|
| Locked | Locked | Locked |
Online platform producing smart soil
|
Detailed competitors of Aphea.Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aphea.Bio
Complete news archive for Aphea.Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aphea.Bio
Aphea.Bio was founded in 2017.
Aphea.Bio is headquartered in Zwijnaarde, Belgium. It is registered at Zwijnaarde, East Flanders, Belgium.
Isabel Vercauteren is the current CEO of Aphea.Bio. They have also founded this company.
Aphea.Bio is a funded company, having raised a total of $108.83M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Aphea.Bio is 40.
Aphea.Bio was established in 2017 in Zwijnaarde, Belgium, within the agricultural biotechnology sector. Bio-pesticides are developed as substitutes for chemical pesticides, while bio-stimulants are created to enhance crop growth through microorganism-assisted nutrient uptake from soil. Solutions are provided to farmers and growers to support sustainable farming practices across operations.
Aphea.Bio has 17 investors. Key investors include KU Leuven, BNP Paribas Fortis, Gates Foundation, PMV, and VIB.